SG Americas Securities LLC Invests $268,000 in Privia Health Group, Inc. $PRVA

SG Americas Securities LLC acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 11,668 shares of the company’s stock, valued at approximately $268,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PRVA. CWM LLC grew its holdings in Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after purchasing an additional 604 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Privia Health Group in the 1st quarter worth about $625,000. Avantax Advisory Services Inc. grew its stake in Privia Health Group by 19.7% in the 1st quarter. Avantax Advisory Services Inc. now owns 15,039 shares of the company’s stock valued at $338,000 after acquiring an additional 2,474 shares during the last quarter. Cetera Investment Advisers grew its stake in Privia Health Group by 3.9% in the 1st quarter. Cetera Investment Advisers now owns 61,936 shares of the company’s stock valued at $1,390,000 after acquiring an additional 2,338 shares during the last quarter. Finally, Federated Hermes Inc. increased its holdings in Privia Health Group by 19.3% during the 1st quarter. Federated Hermes Inc. now owns 29,728 shares of the company’s stock valued at $667,000 after acquiring an additional 4,804 shares in the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Stock Performance

Shares of PRVA opened at $24.38 on Monday. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The company has a market capitalization of $3.00 billion, a PE ratio of 187.51, a price-to-earnings-growth ratio of 4.06 and a beta of 0.83. The stock has a fifty day moving average of $24.41 and a two-hundred day moving average of $22.77.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The business had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%. As a group, equities research analysts forecast that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on PRVA shares. Barclays upped their price target on shares of Privia Health Group from $22.00 to $23.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a report on Tuesday, November 25th. Stephens reissued an “overweight” rating and issued a $32.00 price target on shares of Privia Health Group in a report on Wednesday, September 24th. Evercore ISI upped their price objective on Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Finally, Truist Financial reaffirmed a “buy” rating and set a $31.00 price objective (up previously from $30.00) on shares of Privia Health Group in a research note on Monday, November 10th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Privia Health Group currently has an average rating of “Moderate Buy” and an average target price of $30.00.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.